| Affymax sees 2nd-quarter profit on payment from Hematide partner Takeda ... - CanadianBusiness.com |
|
|
CanadianBusiness.comThe company said its regulatory strategy now involves pursuing an application for treatment of anemia in dialysis patients, while continuing to evaluate the ...Affymax and Takeda Announce Preliminary US Registration Strategy for ... read more |